Related Experiment Video
Updated: Jan 2, 2026

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol
Published on: April 4, 2018
Endothelial cells in colorectal cancer
Wu-Zhen Chen1, Jing-Xin Jiang1, Xiu-Yan Yu1
1Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang Province, China.
Tumor angiogenesis, driven by vascular endothelial growth factors (VEGFs), is crucial for colorectal cancer (CRC) growth and metastasis. Tumor-associated endothelial cells (TECs) play a key role in CRC progression and immune remodeling.
Area of Science:
- Oncology
- Cancer Biology
- Vascular Biology
Background:
- Tumor growth heavily relies on neovascularization, a critical process in tumorigenesis, growth, and metastasis.
- Tumor-associated endothelial cells (TECs) are increasingly recognized for their significant roles in colorectal cancer (CRC) development, including epithelial proliferation, stem cell maintenance, angiogenesis, and immune remodeling.
- Vascular endothelial growth factors (VEGFs) and their receptors are central to tumor angiogenesis and are primary targets for anti-angiogenesis therapies.
Purpose of the Study:
- To review the characteristics of tumor vasculature and the multifaceted roles of TECs in various stages of CRC.
- To elucidate the biological effects of VEGFs and their receptor family in regulating angiogenesis.
- To highlight the clinical implications of TECs in the treatment of colorectal cancer.
Main Methods:
- Literature review focusing on tumor angiogenesis, TECs, and VEGF signaling in colorectal cancer.
- Analysis of existing research on the molecular mechanisms of angiogenesis and its role in CRC.
- Synthesis of information regarding the clinical significance of TECs and VEGFs in CRC treatment strategies.
Main Results:
- VEGFs and their receptors are key regulators of tumor angiogenesis, with overexpression correlating with poor prognosis in CRC.
- TECs contribute to CRC progression through mechanisms involving epithelial proliferation, stem cell maintenance, angiogenesis, and immune modulation.
- Understanding TECs and VEGF signaling provides insights into potential therapeutic targets for CRC.
Conclusions:
- Tumor angiogenesis, mediated by TECs and VEGF signaling, is a fundamental aspect of colorectal cancer progression.
- Targeting TECs and VEGF pathways holds significant promise for developing effective anti-cancer therapies for CRC.
- Further research into the complex interactions within the tumor microenvironment, particularly involving TECs, is essential for advancing CRC treatment.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Selectins
Regulation of Angiogenesis and Blood Supply
Overview of the Vascular System
Renewal of Intestinal Stem Cells

